PINNACLE FINANCIAL PARTNERS INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 136 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 5.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
PINNACLE FINANCIAL PARTNERS INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$45,990
-20.0%
1,0000.0%0.00%0.0%
Q2 2023$57,470
+53.3%
1,0000.0%0.00%0.0%
Q1 2023$37,500
+33.8%
1,0000.0%0.00%0.0%
Q4 2022$28,020
+0.1%
1,0000.0%0.00%0.0%
Q3 2022$28,000
-20.0%
1,0000.0%0.00%0.0%
Q2 2022$35,000
-2.8%
1,0000.0%0.00%0.0%
Q1 2022$36,000
+56.5%
1,0000.0%0.00%0.0%
Q4 2021$23,000
+21.1%
1,0000.0%0.00%0.0%
Q3 2021$19,000
-5.0%
1,0000.0%0.00%0.0%
Q2 2021$20,0000.0%1,0000.0%0.00%0.0%
Q1 2021$20,000
+5.3%
1,0000.0%0.00%0.0%
Q4 2020$19,0000.0%1,0000.0%0.00%0.0%
Q3 2020$19,000
-13.6%
1,0000.0%0.00%0.0%
Q2 2020$22,000
+46.7%
1,0000.0%0.00%0.0%
Q1 2020$15,000
-21.1%
1,0000.0%0.00%0.0%
Q4 2019$19,000
-5.0%
1,0000.0%0.00%
-50.0%
Q1 2019$20,000
+5.3%
1,0000.0%0.00%0.0%
Q3 2018$19,000
+26.7%
1,0000.0%0.00%
+100.0%
Q2 2018$15,000
-21.1%
1,0000.0%0.00%
-50.0%
Q1 2018$19,0001,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders